The Beidaihe Saiaojin Cancer Hospital International Alliance serves as a pivotal strategic platform for the Sino-US Saiaojin Cancer Chain Group's expansion into the Bohai Economic Zone and its deep integration of healthcare and precision oncology. Leveraging the group's core biopharmaceutical technologies, global industrial resources, and international operational capabilities, the alliance concentrates on precision oncology, cell technology translation, and high-end rehabilitation medicine. It aims to establish an international oncology medical and rehabilitation complex that encompasses clinical diagnosis and treatment, scientific research and innovation, as well as rehabilitation and wellness.